Menu
GeneBe

rs74626221

Variant summary

Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBS1BS2

The NM_000027.4(AGA):c.34G>T(p.Val12Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0202 in 1,614,112 control chromosomes in the GnomAD database, including 415 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another nucleotide change resulting in same amino acid change has been previously reported as Uncertain significancein ClinVar.

Frequency

Genomes: 𝑓 0.015 ( 27 hom., cov: 32)
Exomes 𝑓: 0.021 ( 388 hom. )

Consequence

AGA
NM_000027.4 missense

Scores

18

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:5

Conservation

PhyloP100: -1.74
Variant links:
Genes affected
AGA (HGNC:318): (aspartylglucosaminidase) This gene encodes a member of the N-terminal nucleophile (Ntn) hydrolase family of proteins. The encoded preproprotein is proteolytically processed to generate alpha and beta chains that comprise the mature enzyme. This enzyme is involved in the catabolism of N-linked oligosaccharides of glycoproteins. It cleaves asparagine from N-acetylglucosamines as one of the final steps in the lysosomal breakdown of glycoproteins. Mutations in this gene are associated with the lysosomal storage disease aspartylglycosaminuria that results in progressive neurodegeneration. Alternative splicing results in multiple transcript variants, at least one of which encodes an isoform that is subject to proteolytic processing. [provided by RefSeq, Nov 2015]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -12 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0030047).
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.015 (2282/152348) while in subpopulation NFE AF= 0.0232 (1580/68028). AF 95% confidence interval is 0.0223. There are 27 homozygotes in gnomad4. There are 1030 alleles in male gnomad4 subpopulation. This position pass quality control queck.
BS2
High Homozygotes in GnomAd at 27 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
AGANM_000027.4 linkuse as main transcriptc.34G>T p.Val12Leu missense_variant 1/9 ENST00000264595.7
AGANM_001171988.2 linkuse as main transcriptc.34G>T p.Val12Leu missense_variant 1/9
AGAXM_047449722.1 linkuse as main transcriptc.34G>T p.Val12Leu missense_variant 1/7
AGANR_033655.2 linkuse as main transcriptn.96G>T non_coding_transcript_exon_variant 1/8

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
AGAENST00000264595.7 linkuse as main transcriptc.34G>T p.Val12Leu missense_variant 1/91 NM_000027.4 P1
AGAENST00000506853.5 linkuse as main transcriptn.68G>T non_coding_transcript_exon_variant 1/62
AGAENST00000510955.5 linkuse as main transcriptn.68G>T non_coding_transcript_exon_variant 1/42
AGAENST00000511231.1 linkuse as main transcriptn.68G>T non_coding_transcript_exon_variant 1/22

Frequencies

GnomAD3 genomes
AF:
0.0150
AC:
2283
AN:
152230
Hom.:
27
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00403
Gnomad AMI
AF:
0.0899
Gnomad AMR
AF:
0.0177
Gnomad ASJ
AF:
0.0222
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00186
Gnomad FIN
AF:
0.00320
Gnomad MID
AF:
0.0380
Gnomad NFE
AF:
0.0232
Gnomad OTH
AF:
0.0239
GnomAD3 exomes
AF:
0.0144
AC:
3609
AN:
251166
Hom.:
48
AF XY:
0.0145
AC XY:
1971
AN XY:
135860
show subpopulations
Gnomad AFR exome
AF:
0.00481
Gnomad AMR exome
AF:
0.0117
Gnomad ASJ exome
AF:
0.0209
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00402
Gnomad FIN exome
AF:
0.00481
Gnomad NFE exome
AF:
0.0225
Gnomad OTH exome
AF:
0.0223
GnomAD4 exome
AF:
0.0208
AC:
30384
AN:
1461764
Hom.:
388
Cov.:
34
AF XY:
0.0205
AC XY:
14883
AN XY:
727194
show subpopulations
Gnomad4 AFR exome
AF:
0.00370
Gnomad4 AMR exome
AF:
0.0127
Gnomad4 ASJ exome
AF:
0.0209
Gnomad4 EAS exome
AF:
0.0000252
Gnomad4 SAS exome
AF:
0.00428
Gnomad4 FIN exome
AF:
0.00537
Gnomad4 NFE exome
AF:
0.0244
Gnomad4 OTH exome
AF:
0.0202
GnomAD4 genome
AF:
0.0150
AC:
2282
AN:
152348
Hom.:
27
Cov.:
32
AF XY:
0.0138
AC XY:
1030
AN XY:
74498
show subpopulations
Gnomad4 AFR
AF:
0.00402
Gnomad4 AMR
AF:
0.0177
Gnomad4 ASJ
AF:
0.0222
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00186
Gnomad4 FIN
AF:
0.00320
Gnomad4 NFE
AF:
0.0232
Gnomad4 OTH
AF:
0.0237
Alfa
AF:
0.0206
Hom.:
49
Bravo
AF:
0.0158
TwinsUK
AF:
0.0243
AC:
90
ALSPAC
AF:
0.0249
AC:
96
ESP6500AA
AF:
0.00499
AC:
22
ESP6500EA
AF:
0.0260
AC:
224
ExAC
AF:
0.0144
AC:
1753
Asia WGS
AF:
0.00202
AC:
7
AN:
3478
EpiCase
AF:
0.0274
EpiControl
AF:
0.0247

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:5
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Aspartylglucosaminuria Uncertain:1Benign:3
Benign, criteria provided, single submitterclinical testingInvitaeFeb 01, 2024- -
Likely benign, criteria provided, single submitterliterature onlyCounsylSep 19, 2014- -
Uncertain significance, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 27, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -
Benign, no assertion criteria providedclinical testingNatera, Inc.Dec 02, 2019- -
not provided Benign:2
Benign, criteria provided, single submitterclinical testingGeneDxNov 27, 2018This variant is associated with the following publications: (PMID: 11309371) -
Likely benign, no assertion criteria providedclinical testingMayo Clinic Laboratories, Mayo ClinicApr 25, 2017- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.061
BayesDel_addAF
Benign
-0.55
T
BayesDel_noAF
Benign
-0.55
Cadd
Benign
0.20
Dann
Benign
0.65
DEOGEN2
Benign
0.087
T
Eigen
Benign
-1.6
Eigen_PC
Benign
-1.6
FATHMM_MKL
Benign
0.033
N
LIST_S2
Benign
0.40
T
MetaRNN
Benign
0.0030
T
MetaSVM
Benign
-0.75
T
MutationAssessor
Benign
-0.71
N
MutationTaster
Benign
1.0
N
PrimateAI
Benign
0.45
T
PROVEAN
Benign
0.17
N
REVEL
Benign
0.23
Sift
Benign
0.70
T
Sift4G
Benign
1.0
T
Polyphen
0.0020
B
Vest4
0.068
MutPred
0.79
Loss of sheet (P = 0.0011);
MPC
0.11
ClinPred
0.0061
T
GERP RS
-7.2
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Varity_R
0.040
gMVP
0.40

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs74626221; hg19: chr4-178363496; COSMIC: COSV52806729; COSMIC: COSV52806729; API